NEI
CAI icon

Northwest & Ethical Investments’s Caris Life Sciences CAI Stock Holding History

Northwest & Ethical Investments’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.6K Sell
4,727
-7,773
-62% -$139K ﹤0.01% 487
2026
Q1 		$238K Buy
12,500
+1,900
+18% +$41.5K 0.01% 473
2025
Q4 		$290K Buy
+10,600
New +$299K 0.01% 450

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PointState Capital
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northwest & Ethical Investments's CAI Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its Caris Life Sciences (CAI) stake by 62% in Q2 2026, selling an estimated $139K and leaving 4,727 shares worth $86.6K. The position accounts for ﹤0.01% of the portfolio, ranked #487.

Northwest & Ethical Investments first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. The position peaked at $290K in Q4 2025. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Northwest & Ethical Investments held 4,727 shares of Caris Life Sciences worth $86.6K as of Q2 2026.
  • Northwest & Ethical Investments sold 7,773 Caris Life Sciences shares in Q2 2026, an estimated $139K.
  • Caris Life Sciences made up ﹤0.01% of Northwest & Ethical Investments's portfolio in Q2 2026, its #487 holding.
  • Northwest & Ethical Investments first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • Northwest & Ethical Investments's Caris Life Sciences position peaked at $290K in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.